Skip to main content
SpringerLink
Log in

Sulphasalazine in arthritis — an old drug rediscovered

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Sulphasalazine (salicyl-azo-sulphapyridine) has been in clinical use for over 40 years. Although the drug was originally introduced for the treatment of ‘rheumatic polyarthritis’ and ulcerative colitis, it is only in the past 10 years that its value in rheumatology has been appreciated. Controlled studies indicate that the drug is an effective remittive agent in both rheumatoid arthritis and ankylosing spondylitis. This is an area of great research interest since the drug is proving to be a useful tool for investigating the aeteology and pathogenesis of these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Svartz, N. Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 1942, 110, 577–98.

    Google Scholar 

  2. Sinclair, R.J.G., Duthie, J.J.R. Salazopyrin in the treatment of rheumatoid arthritis. Ann Rheum Dis 1948, 8, 226–31.

    Google Scholar 

  3. Kuzell, W.C., Gardner, G.M. Salicylazosulfapyridine (salazopyrin or azopyrin) in rheumatoid arthritis and experimental polyarthritis. Calif Med 1950, 73, 476–80.

    Google Scholar 

  4. Misiewicz, J.J., Lennard-Jones, J.E., Connell, A.M., Baron, J.H., Avery Jones, F. Controlled trial of sulphasalazine in ulcerative colitis. Lancet 1965, 1, 185–8.

    Google Scholar 

  5. McConkey, B., Davies, P., Crockson, R.A., Crockson, A.P., Butler, M., Constable, T.J. Dapsone in rheumatoid arthritis. Rheumatol Rehabil 1976, 15, 230–4.

    Google Scholar 

  6. McConkey, B., Amos, R.S., Butler, E.P., Crockson, R.A., Crockson, A.P., Walsh, L. Salazopyrin in rheumatoid arthritis. Agents Actions 1978, 8, 438–41.

    Google Scholar 

  7. Neumann, V.C., Grindulis, K.A., Hubball, S., McConkey, B., Wright, V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham Trial. Br Med J 1983, 287, 1089–1102.

    Google Scholar 

  8. Pullar, T., Hunter, J.A., Capell, H.A. Sulphasalazine in rheumatoid arthritis: a double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 1983, 287, 1102–4.

    Google Scholar 

  9. Dew, M.J., Hughes, P., Harries, A.D., Williams, G., Evans, B.K., Rhodes, J. Mintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J 1982, 285, 1012.

    Google Scholar 

  10. Pullar, T., Hunter, J.A., Capell, H.A. Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J 1985, 290, 1535–8.

    Google Scholar 

  11. Neumann, V.C., Taggart, A.J., Le Gallez, P., Astbury, C., Hill, J., Bird, H.A. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J Rheumatol 1986, 13, 285–7.

    Google Scholar 

  12. Ash, G., Baker, R., Rajapakse, C., Swinson, D.R. Study of sulphamethoxazole in rheumatoid arthritis. Br J Rheumatol 1986, 25, 285–7.

    Google Scholar 

  13. Astbury, C., Hill, J., Bird, H.A. Co-trimoxazole (CTZ) in rheumatoid arthritis. Br J Rheumatol 1986, 25 Suppl 2, Abstract 46.

  14. Pullar, T., Hunter, J.A., Capell, H.A. Sulphasala-zine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol 1985, 24, 269–76.

    Google Scholar 

  15. Mielants, H., Veys, E.M. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulphasalazine (salazopyrin) in HLA-B27 related reactive arthritis. J Rheumatol 1985, 12, 287–93.

    Google Scholar 

  16. Mielants, H., Veys, E.M., Joos, R. Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986, 5, 80–83.

    Google Scholar 

  17. Peliskova, Z., Vacha, J., Trnavsky, K. Sulphasalazine in reactive arthritis: an open trial. Br J Rheumatol 1986, 25 Suppl 2, Abstract 49.

  18. Feltelius, N., Hallgren, R. Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis 1986, 45, 396–9.

    Google Scholar 

  19. Dougados, M., Boumier, P., Amor, B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br Med J 1986, 293, 911–4.

    Google Scholar 

  20. Das, K.M., Eastwood, M.A., McManus, J.P.A., Sircus, W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 1973, 289, 491–5.

    Google Scholar 

  21. Pullar, T., Hunter, J.A., Capell, H.A., Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis 1985, 44, 831–7.

    Google Scholar 

  22. Bax, D.E., Amos, R.S. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash. Ann Rheum Dis 1986, 45, 139–40.

    Google Scholar 

  23. Farr, M., Symmons, D.P.M., Bacon, P.A. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine. Ann Rheum Dis 1985, 44, 798–800.

    Google Scholar 

  24. Thomas, P., Seaton, A., Edwards, J. Respiratory disease due to sulphasalazine. Clin Allergy 1974, 4, 41–7.

    Google Scholar 

  25. Raforth, R.J. Systemic granulomatous reaction due to salicylsulfapyridine (azulfidine) in a patient with Crohn's disease. Am J Dig Dis 1974, 19, 465–9.

    Google Scholar 

  26. Crisp, A.J. Sulphasalazine in rheumatoid arthritis (letter). Br J Rheumatol 1984, 23, 232.

    Google Scholar 

  27. Toth, A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 1979, 31, 538–40.

    Google Scholar 

  28. Levi, A.J., Fischer, A.M., Hughes, L., Hendry, W.F. Male infertility due to sulphasalazine. Lancet 1979 ii, 276–8.

    Google Scholar 

  29. Givercman, A., Skakkeboek, N.E. The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. Int J Androl 1986, 9, 38–52.

    Google Scholar 

  30. Grindulis, K., McConkey, B. Does sulphasalazine cause folate deficiency in rheumatoid arthritis? Scand J Rheumatol 1985, 14, 265–70.

    Google Scholar 

  31. Van de Pette, J.E.W., Cunnah, D.T.E., Shallcross, T.M. Bone marrow necrosis after treatment with sulphasalazine. Br Med J 1984, 289, 798.

    Google Scholar 

  32. Amos, R.S., Pullar, T., Bax, D., Situnayake, D., Capell, H.A., McConkey, B. Sulphasalazine for rheumatoid arthritis: Toxicity in 774 patients monitored for one to eleven years. Br Med J 1986, 293, 420–2.

    Google Scholar 

  33. Bax, D.E., Amos, R.S. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Ann Rheum Dis 1985, 44, 194–8.

    Google Scholar 

  34. Wright, V. Regular Review: treatment of severe rheumatoid arthritis. Br Med J 1986, 292, 431–2.

    Google Scholar 

  35. Klotz, U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinetics 1985, 10, 285–302.

    Google Scholar 

  36. Azad Khan, A.K., Piris, J., Truelove, S.C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977, ii, 392–5.

    Google Scholar 

  37. Taggart, A.J., McDermott, B., Delargy, M., El-born, S., Forbes, J., Roberts, S.D., Ahnfelt, N-O. The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis. Scand J Rheumatol 1987, in press.

  38. Bickers, D.R., Hazen, P.G., Lynch, W.S. (Eds). Sulfones and sulphapyridine. In: Clinical Pharmacology of Skin Disease. London: Churchill Livingstone, 1984, 217–34.

    Google Scholar 

  39. Olhagen, B., Mansson, I. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med Scand 1968, 184, 395–402.

    Google Scholar 

  40. Shinebaum, R., Neumann, V., Wright, V., Cooke, E.M. Comparison of faecal flora of patients with rheumatoid arthritis and controls. J Med Microbiol 1984, 18, Abstract No. IV.

  41. West, B., Lendrum, R., Hill, M.J., Walker, G. Effects of sulphasalazine (salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut 1974, 15, 960–5.

    Google Scholar 

  42. Mielants, H., Veys, E.M. Inflammation of the ileum in patients with B27-positive reactive arthritis. Lancet 1984, 1, 288.

    Google Scholar 

  43. Mielants, H., Veys, E.M. Reiter's syndrome and reactive arthritis. New Engl J Med 1984, 310, 1538.

    Google Scholar 

  44. Mielants, H., Veys, E.M., Cuvelier, C. et al. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol 1985, 294–298.

Download references

Author information

Authors and Affiliations

  1. Department of Therapeutics and Pharmacology, Queen's University of Belfast, BT9 7BL, Belfast, Northern Ireland

    A. J. Taggart

Authors
  1. A. J. Taggart
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taggart, A.J. Sulphasalazine in arthritis — an old drug rediscovered. Clin Rheumatol 6, 378–383 (1987). https://doi.org/10.1007/BF02206836

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02206836

Key words

Search

Navigation